Prosecution Insights
Last updated: October 25, 2026

Invitrogen Bioservices India Private Limited

Technology area: Communications

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Invitrogen Bioservices India Private Limited has 1 pending office action in the Communications technology area. This action is assigned to 1 distinct examiner, OSIFADE, IDOWU O, in 1 distinct art unit. OSIFADE, IDOWU O is the busiest examiner, managing the 1 pending office action currently active. This single action defines the current prosecution landscape for the portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§102 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
1
Communications
100% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
OSIFADE, IDOWU O 1 81.5% +12.3%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19046295 SYSTEMS AND METHODS FOR IDENTIFYING GROUPINGS OF CELLS OSIFADE, IDOWU O —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19046295 SYSTEMS AND METHODS FOR IDENTIFYING GROUPINGS OF CELLS OSIFADE, IDOWU O —

Top Art Units

Art UnitApps
2675 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19046295 SYSTEMS AND METHODS FOR IDENTIFYING GROUPINGS OF CELLS OSIFADE, IDOWU O 2675 §102 Non-Final OA — Pending Feb 05, 2025

Managing Invitrogen Bioservices India Private Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Invitrogen Bioservices India Private Limited have?

Invitrogen Bioservices India Private Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Invitrogen Bioservices India Private Limited applications?

Idowu O Osifade has the most, with 1 of Invitrogen Bioservices India Private Limited's pending office actions.

What technology area are Invitrogen Bioservices India Private Limited's patent applications in?

Mostly Communications (USPTO Tech Center 2600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month